<DOC>
	<DOCNO>NCT02013180</DOCNO>
	<brief_summary>Although Prostate Specific Antigen ( PSA ) useful marker early detection prostate cancer , specivity sufficient . Several PSA variation define order increase specivity test , n't much effective PSA alone detection disease . In old study report , serum prostatic tissue zinc level decrease prostat cancer disease . In study aim establish utility serum zinc , PSA , free PSA/PSA ( fPSA/tPSA ) , zinc/PSA , level early detection prostate cancer .</brief_summary>
	<brief_title>Zinc/PSA Ratio Novel Biomarker Prostate Cancer Detection</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients LUTS elevate serum PSA level and/or suspicious rectal examination usage zinc include drug , old prostatic operation , old prostatic radiotherapy , old prostatic biopsy , chronic rectal disease ( anal fissure , hemorrhoid , etc.. ) , PIN ( prostatic intraepithelial neoplasia ) ASAP ( atypical small acinar proliferation ) pathologic evaluation .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Prostate cancer , PSA , zinc , zinc/PSA</keyword>
</DOC>